10/28/2026
Pharma giants invest billions in psychedelics despite hurdles
Psychedelics like MDMA and psilocybin gain traction amid regulatory challenges.
Topic archive
psychedelic drugs
18 stories
10/9/2026
FDA seeks public input on ibogaine trials
Gabon aims to secure benefits from rising ibogaine demand
10/8/2026
Ibogaine shows promise for PTSD relief in veterans
Study finds significant symptom improvement in PTSD, depression after ibogaine treatment.
10/8/2026
FDA proposes ibogaine trial design, seeks input
FDA outlines early-stage ibogaine trial design, inviting public feedback.
10/5/2026
FDA seeks public input on ibogaine research
Agency requests feedback on clinical trial design for ibogaine drug products.
9/23/2026
Understanding the psychedelic drug ibogaine
Ibogaine is explored for its potential in treating addiction and mental health.
9/21/2026
Presley Gerber's ibogaine treatment detailed before tragic death
Cindy Crawford's son shared his ibogaine experience months before passing in rehab.
9/21/2026
Presley Gerber's ibogaine treatment in Mexico before death
Model Presley Gerber underwent ibogaine therapy in Cancun months before his passing.
9/16/2026
FDA hearing highlights psychedelic drug trial safety
Public feedback sought on psychedelic drugs' therapeutic potential and safety measures.
9/10/2026
FDA outlines new psychedelic drug framework in NEJM
The FDA highlights its evolving approach to psychedelic therapies amid a mental health crisis.
8/20/2026
Trump's FDA pick linked to Joe Rogan-backed psychedelic policy
Dr. Heidi Overton, nominated by Trump, expedited psychedelic research policy.
8/19/2026
Trump supports psychedelic drugs for veterans' mental health
Former President Trump advocates for psychedelic treatment to aid veterans.
8/19/2026
Trump highlights ibogaine in executive order on psychedelics
The executive order aims to expedite research on ibogaine and other psychedelics.
8/18/2026
University of Miami gifts ibogaine application to FDA
The move aims to expedite ibogaine research under a new executive order.
8/5/2026
Barrow Neurological Institute receives $5M for ibogaine study
Grant supports research into ibogaine's effects on neurological disorders.
7/24/2026
Joe Rogan's ibogaine advocacy sparks White House tension
Rogan's push for ibogaine approval led to conflict with a key Trump aide.
7/19/2026
Psychedelic drugs market sees positive growth signal
Investment interest grows in psychedelics for mental health treatment.
7/16/2026
San Antonio mayor advocates for ibogaine trials
Mayor Gina Ortiz Jones pushes for psychedelic trials to aid veterans.